The expression of tyrosinase in these cells was indicated by a marked reduction in viability upon exposure to the anti-melanoma agent 4-S-cysteaminylphenol (4SCAP, 300 μM), while there was no reduced viability in mock-transfected cells (Figure S16c). The gene discussed is TYR; the disease is melanoma.